SRD5A3 and urinary bladder cancer: Therefore, we concluded that SRD5A3 and IGF2BP3 play oncogenic roles in bladder tumorigenesis, and IGF2BP3 directly interacts with SRD5A3 mRNA and increases its stability during cisplatin resistance development in bladder cancer.